Almac appoints US vice president of business development


October 31, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almac, seigel
Contract manufacturing firm Almac has hired Richard Segiel Jr as its vice president of Business Development for the US. He …
Sanofi cuts earnings guidance despite return to sales growth
October 31, 2013Sales and Marketing Sanofi, Viehbacher, vaccines
Sanofi cut its earnings guidance for 2013 after its third quarter results missed targets, despite a return – barely – …
GSK strikes new vaccines deal with Gates Foundation
October 30, 2013Research and Development, Sales and Marketing GSK, Gates, bmgf, vaccines
GSK and the Bill & Melinda Gates Foundation (BMGF) will invest a combined $1.8 million in early-stage research into making …
Cancer drugs lift Pfizer in third quarter
October 30, 2013Sales and Marketing Lipitor, Lyrica, Pfizer, Q3, Xalkori
Pfizer saw a drop in revenue for the third quarter but the future looks bright as new products begin to …
Unpublished trials ‘violates ethical obligation’ to patients
October 30, 2013Research and Development, Sales and Marketing BMJ, Goldacre, all trials, trials
A new study published in the BMJ has found almost one in three (29%) of large clinical trials remain unpublished …
Aesica hires business development manager and director
October 30, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aesica, muganga
Contract development and manufacturing organisation (CDMO) Aesica has appointed Baali Muganga to the role of east coast US business development …
‘Game-changing’ hep C pill gets FDA panel nod
October 29, 2013Sales and Marketing FDA, Gilead, hep C, sofosbuvir
Gilead Science’s investigational hepatitis C drug sofosbuvir is one step closer to approval in the US after an FDA advisory …
Strong sales for Biogen Idec’s MS drug
October 29, 2013Sales and Marketing Biogen IDEC, Q3, gilenya, tecfidera
Biogen Idec’s oral multiple sclerosis (MS) drug Tecfidera lived up to its blockbuster-in-waiting billing with third quarter sales that exceeded …
Amgen promotes two senior executives
October 29, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen
Amgen has promoted two senior executives as Brian McNamee becomes executive vice president and Stuart Tross senior vice president. McNamee …
New online tool to hear lung cancer patients’ stories
October 29, 2013Medical Communications, Sales and Marketing Boehringer, NSCLC, glcc, lung cancer
The Global Lung Cancer Coalition and Boehringer Ingelheim have teamed-up to increase awareness of the challenges facing individuals and families …
PMCPA: Sanofi ‘discredited pharma’
October 28, 2013Medical Communications, Sales and Marketing ABPI, PMCPA, Sanofi, breach
Sanofi has lowered the public’s confidence in the pharma industry, according to the PMCPA, which enforces the ABPI Code of …
Novo recalls insulin shots on mis-dosing fears
October 28, 2013Manufacturing and Production Novo Nordisk, flexpen, novomix, recall
Novo Nordisk is recalling around 3 million insulin products used to treat diabetes in Europe because of a possible manufacturing …
Positive CHMP verdicts for Actelion and Lundbeck
October 28, 2013Sales and Marketing Actelion, CHMP, FDA, Lundbeck
Actelion and Lundbeck both took a step closer to EU approval for two drugs seen as pivotal to their future …
Strategic planning: don’t just do it, use it
October 28, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, craig, strategic planning
Every year, thousands of pharma employees spend endless hours in meetings discussing, building and presenting brand plans. Countless teams develop …
Sanofi starts C. diff study
October 28, 2013Research and Development, Sales and Marketing C diff, Sanofi Pasteur, cdi, clostridium
Sanofi’s vaccines division is beginning a Phase III programme looking at the safety and effectiveness of an investigational treatment for …
Shire hires finance director
October 28, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, dominic blakemore
Dominic Blakemore will join Shire’s Board from January next year as a non-executive director and member of its Audit, Compliance …
AstraZeneca to close Brixham environmental lab
October 25, 2013Manufacturing and Production API, AstraZeneca, brixham
AstraZeneca’s UK workers are facing more disruption following the company’s decision to close down a laboratory in Brixham focussing on …
Samsung signs biologics deal with Roche
October 25, 2013Manufacturing and Production Korea, Roche, Samsung
Roche is leaving nothing to chance in its pursuit of the biologics drug market, adding to its internal investment programme …
Sharon Hurley
October 25, 2013Medical Communications, Sales and Marketing Med Comms
Synergy Vision expands client services team to meet demand in UK and Ireland Award-winning medical communications agency Synergy Vision is …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
AI: an early warning system for patient safety
Highlighting the value of lab research for healthcare innovation
